Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic

Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease

NCT03801928 ·Status: COMPLETED

Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases

NCT02508012 ·Status: COMPLETED ·Phase: NA

Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease

NCT04818892 ·Status: COMPLETED

Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.

NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA

An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis

NCT02497469 ·Status: COMPLETED ·Phase: PHASE3

A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease

NCT02904590 ·Status: COMPLETED

Covid-19 Vaccine Responses in Patients With Inflammatory Bowel Diseases

NCT05067959 ·Status: UNKNOWN

PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease

NCT06758024 ·Status: RECRUITING ·Phase: NA

Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis

NCT03724929 ·Status: TERMINATED ·Phase: NA

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

NCT00036439 ·Status: COMPLETED ·Phase: PHASE3

Assessment of the Response to the Complete Vaccination Guidelines Against Sars-cov2

NCT05153850 ·Status: UNKNOWN

FMT in Inflammatory Bowel Disease

NCT03477032 ·Status: UNKNOWN

Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

NCT05014555 ·Status: UNKNOWN

An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis

NCT00355901 ·Status: TERMINATED

PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic

NCT04410484 ·Status: COMPLETED

Genetic an Functional Studies of Patient With Inflammatory Bowel Disease

NCT03751722 ·Status: COMPLETED

Magnetic Resonance Enterography in Inflammatory Bowel Diseases

NCT04324632 ·Status: UNKNOWN

Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients

NCT05927064 ·Status: COMPLETED

National Multicentric Observatory of Low Bowel Preparations in Patients With IBD

NCT03753425 ·Status: COMPLETED

Comparison of Trough Level- and Clinical-based Spacing of Infliximab Infusions in Patients With IBD in Deep Remission

NCT03841942 ·Status: TERMINATED ·Phase: NA

Metabolic Reprogramming of Monocytes in Inflammatory Flares of Inflammatory Bowel Diseases

NCT06944873 ·Status: NOT_YET_RECRUITING

Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment

NCT05406934 ·Status: UNKNOWN

Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease

NCT02693340 ·Status: UNKNOWN

Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral Blood Mononuclear Cells

NCT03043677 ·Status: COMPLETED

Evolution and Treatments of Chronic Inflammatory Systemic Diseases

NCT04191395 ·Status: RECRUITING